Trigeminal neuralgia
New classification and diagnostic grading for practice and research
Citation Manager Formats
Make Comment
See Comments

Abstract
Trigeminal neuralgia (TN) is an exemplary condition of neuropathic facial pain. However, formally classifying TN as neuropathic pain based on the grading system of the International Association for the Study of Pain is complicated by the requirement of objective signs confirming an underlying lesion or disease of the somatosensory system. The latest version of the International Classification of Headache Disorders created similar difficulties by abandoning the term symptomatic TN for manifestations caused by major neurologic disease, such as tumors or multiple sclerosis. These diagnostic challenges hinder the triage of TN patients for therapy and clinical trials, and hamper the design of treatment guidelines. In response to these shortcomings, we have developed a classification of TN that aligns with the nosology of other neurologic disorders and neuropathic pain. We propose 3 diagnostic categories. Classical TN requires demonstration of morphologic changes in the trigeminal nerve root from vascular compression. Secondary TN is due to an identifiable underlying neurologic disease. TN of unknown etiology is labeled idiopathic. Diagnostic certainty is graded possible when pain paroxysms occur in the distribution of the trigeminal nerve branches. Triggered paroxysms permit the designation of clinically established TN and probable neuropathic pain. Imaging and neurophysiologic tests that establish the etiology of classical or secondary TN determine definite neuropathic pain.
GLOSSARY
- DTI=
- diffusion tensor imaging;
- ICHD=
- International Classification of Headache Disorders;
- MS=
- multiple sclerosis;
- TN=
- trigeminal neuralgia
Footnotes
Go to Neurology.org for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article. The article processing charge was paid by the authors.
Supplemental data at Neurology.org
- Received December 4, 2015.
- Accepted in final form April 1, 2016.
- © 2016 American Academy of Neurology
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially.
Letters: Rapid online correspondence
- Trigeminal neuralgia: Is it possible to classify by etiology?
- Silvia R. Siqueira, DDS, PhD, Associate Professor, University of Sao Paulosilviadowgan@hotmail.com
Submitted July 20, 2016
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Jessica Ailani and Dr. Ailna Masters-Israilov
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Article
A dual concurrent mechanism explains trigeminal neuralgia in patients with multiple sclerosisAndrea Truini, Luca Prosperini, Valentina Calistri et al.Neurology, May 04, 2016 -
Articles
A randomized, controlled trial of high-dose dextromethorphan in facial neuralgiasI. Gilron, S.L. Booher, J.S. Rowan et al.Neurology, October 10, 2000 -
Views & Reviews
Trigeminal neuralgiaMechanisms of treatmentRichard B. Tenser et al.Neurology, July 01, 1998 -
Article
Trigeminal Neuralgia TRPM8 MutationEnhanced Activation, Basal [Ca2+]i and Menthol ResponseRoberta Gualdani, Jun-Hui Yuan, Philip R. Effraim et al.Neurology: Genetics, January 11, 2021